Anesthesia Patient Safety Foundation
search APSF.org:
donate/sponsor
apsf homeapsf home about apsfdonorsinitiativesresource centergrants news & eventscontact us
   
 
grants
Grant Application
Guidelines
Recipients
History
Committee
Frequently Asked Questions
 

Grants

 
Print this page
Send to a friend
Request information
More information about our newsletter

2003 Grant Recipients

Ken B. Johnson, MD, Assistant Professor of Anesthesiology in the Department of Anesthesiology at the University of Utah in Salt Lake City. His grant proposal is entitled "Exploration of Partial Task and Variable Priority Training to Improve Management of Adverse Respiratory Events: An Enhanced Approach to Didactic and Simulation-Based Training for Anesthesia Residents." The objective of this proposal is to assess how enhanced didactic and simulator-based training incorporating both part task and variable priority training will impact first-year anesthesia residents' ability to manage life threatening adult and pediatric respiratory events. Part task training is defined as the break-down of large, multi-component tasks into a set of components that can become highly automatized, reducing the processing demands. Variable priority training is a method of teaching residents to distribute attention over multiple aspects of a task. The study will compare standard training for first-year anesthesia residents with enhanced (part task and variable priority-based) training over a twelve month period. Standard training consists of resident participation in weekly didactic sessions (grand rounds, case conferences, chapter reviews, and visiting professor lectures), daily hands-on training in the operating room, and six simulation-based training sessions throughout the year. Part task and variable priority training consists of participation in the same activities as the control group, except that one of the weekly didactic sessions per month will employ part task training, and all six of the simulation-based training sessions employ variable priority training. Each resident's performance in managing six simulated respiratory events will be measured at the beginning and at the end of the twelve month study period. Metrics of comparison between training groups will include the time required to reach diagnosis and the time required to properly treat the simulated respiratory events.
In addition to receiving the requested funding of $65,000 for this project, Dr Johnson is also the recipient of the inaugural "Ellison C. Pierce, Jr. Education Award," which consists of an additional, unrestricted grant of $5,000.

Nyamkhishig Sambuughin, PhD, Assistant Staff Scientist of Neurology Research at the Barrow Neurological Institute, St. Joseph's Hospital and Medical Center in Phoenix, Arizona. Her grant proposal is entitled "Development of Molecular Diagnosis for Malignant Hyperthermia." The objective of this proposal is to screen an entire ryanodine type 1 receptor (RYR1) gene using new molecular genetic technology, and eventually to establish the complete spectrum of RYR1 mutations. The proposal is based on the hypothesis that RYR1 mutations are dispersed throughout the gene, causing malignant hyperthermia (MH) in 80% of affected families. Individuals with MH are usually clinically normal, but they are prone to life-threatening hypermetabolic crises following exposure to inhalational anesthetics or depolarizing muscle relaxants. In the majority of cases, MH results from a defect in the regulation of calcium release in skeletal muscle due to mutations in the calcium-release channel of sarcoplasmic reticulum receptor (RYR1). MH is inherited as an autosomal dominant trait, and when MH susceptibility is diagnosed in an individual, his or her family members are considered at risk for the disease. Currently, MH susceptibility can only be determined by caffeine-halothane contracture test, an invasive procedure that is expensive, not 100% reliable, difficult to perform in children, and only available in 8 diagnostic centers in the United States (3 of which are closing this year due to lack of funding). The proposal seeks to develop a molecular screening test for MH susceptibility, based on the mutation analysis of the RYR1 gene. Genetic diagnosis for MH susceptibility in at-risk individuals will enhance patient safety significantly, and will be far less invasive, highly specific, and relatively inexpensive.

 

 
 

APSF | Building One, Suite Two | 8007 South Meridian Street
Indianapolis, IN 46217-2922 | f. 317.888.1482
e. walker@apsf.org

Last updated: 02.07.2008

Copyright © 2008. Anesthesia Patient Safety Foundation. All rights reserved.